研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2025 年 · SiM
Statistics in Medicine,2025 年发表的 394 篇,新的在前。点标题看作者和摘要。回到 2025 年
- Mendelian Randomization Methods for Causal Inference: Estimands, Identification and Inference · SiM · 2025-12-29 · 在第 1 页
- A Tutorial on Optimal Dynamic Treatment Regimes · SiM · 2025-12-29 · 在第 1 页
- Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models · SiM · 2025-12-20 · 在第 1 页
- Mendelian Randomization With Longitudinal Exposure Data: Simulation Study and Real Data Application · SiM · 2025-12-18 · 在第 1 页
- Semiparametric Partial Functional Regression Model for Estimating Optimal Individualized Treatment Regime · SiM · 2025-12-15 · 在第 1 页
- Addressing Outcome Reporting Bias in Meta‐Analysis: A Selection Model Perspective · SiM · 2025-12-15 · 在第 1 页
- Dynamic Prediction of Analysis Timing in Clinical Trials Using Joint Models of Longitudinal and Time‐to‐Event Data · SiM · 2025-12-14 · 在第 1 页
- A Commentary on Chatterjee Et Al. (2018): A Corrected Framework for Group Sparsity in Zero‐Inflated Negative Binomial Models · SiM · 2025-12-14 · 在第 1 页
- Extension of Bootstrap MARS With Group LASSO for Heterogeneous Treatment Effect Estimation · SiM · 2025-12-11 · 在第 1 页
- Effects Among the Affected · SiM · 2025-12-11 · 在第 2 页
- Inference on Controlled Effects for Assessing Immune Correlates of Protection Based on a Cox Model · SiM · 2025-12-10 · 在第 2 页
- Group‐Sequential Designs With an Externally‐Driven Change of Primary Endpoint · SiM · 2025-12-10 · 在第 2 页
- Bayesian Variable Selection for High-Dimensional Mediation Analysis: Application to Metabolomics Data in Epidemiological Studies · SiM · 2025-12-10 · 在第 2 页
- Assessing Treatment Effects in Observational Data With Missing Confounders: A Comparative Study of Practical Doubly-Robust and Traditional Missing Data Methods · SiM · 2025-12-10 · 在第 2 页
- Variant‐Specific Mendelian Risk Prediction Model · SiM · 2025-12-09 · 在第 2 页
- Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials · SiM · 2025-12-09 · 在第 2 页
- Overview and Practical Recommendations on Using Shapley Values for Identifying Predictive Biomarkers via CATE Modeling · SiM · 2025-12-08 · 在第 2 页
- Nonparametric Bayesian Adjustment of Unmeasured Confounders in Cox Proportional Hazards Models · SiM · 2025-12-08 · 在第 2 页
- The Role of Congeniality in Multiple Imputation for Doubly Robust Causal Estimation · SiM · 2025-12-07 · 在第 2 页
- Survival Analysis Under the Aalen's Additive Hazards Model With Covariate Measurement Error: Application to Causal Mediation Analysis · SiM · 2025-12-07 · 在第 2 页
- Two‐Stage Drop‐the‐Losers Design for the Selection of Effective Treatments and Estimating Their Average Worth · SiM · 2025-12-05 · 在第 2 页
- Likelihood‐Based Non‐Parametric Receiver Operating Characteristic Curve Analysis in the Presence of Imperfect Reference Standard · SiM · 2025-12-05 · 在第 2 页
- Joint Bayesian Hidden Markov Model With Subject‐Specific Transitions for Wearable Sensor Data · SiM · 2025-12-05 · 在第 2 页
- Covariate‐Adjusted Group Sequential Comparisons of Survival Probabilities · SiM · 2025-12-05 · 在第 2 页
- Confidence Interval Construction for Causally Generalized Estimates With Target Sample Summary Information · SiM · 2025-12-04 · 在第 2 页
- Cluster‐Level Analyses to Estimate a Risk Difference in a Cluster Randomized Trial With Confounding Individual‐Level Covariates: A Simulation Study · SiM · 2025-12-04 · 在第 2 页
- A Review of Methods for Research Synthesis · SiM · 2025-12-04 · 在第 2 页
- System of Linear Equations to Derive Unreported Test Accuracy Counts for Meta‐Analysis · SiM · 2025-12-03 · 在第 2 页
- Clustering‐Informed Shared‐Structure Variational Autoencoder for Missing Data Imputation in Large‐Scale Healthcare Data · SiM · 2025-12-03 · 在第 2 页
- Bayesian Integrated Learning of Longitudinal Dose‐Response Relationships via Decentralized Clinical Trials · SiM · 2025-12-03 · 在第 2 页
- Integrating Multiple Clustering Techniques and Performance Measures via Ranking for scRNA‐Seq Data · SiM · 2025-12-02 · 在第 3 页
- Graph Based, Adaptive, Multiarm, Multiple Endpoint, Two‐Stage Designs · SiM · 2025-12-02 · 在第 3 页
- A New Streaming K‐Nearest Neighbor Algorithm for Status Prediction in Block‐Sparse, Autocorrelated, Irregular Longitudinal Data · SiM · 2025-12-02 · 在第 3 页
- Explaining Individualized Treatment Rules: Integrating LIME and SHAP With Xgboost in Precision Medicine · SiM · 2025-12-01 · 在第 3 页
- An Augmented Likelihood Approach Incorporating Error‐Prone Auxiliary Data Into a Survival Analysis · SiM · 2025-12-01 · 在第 3 页
- A Random‐Effects Approach to Generalized Linear Mixed Model Analysis of Incomplete Longitudinal Data · SiM · 2025-12-01 · 在第 3 页
- Group Lasso Based Selection for High-Dimensional Mediation Analysis · SiM · 2025-11-28 · 在第 3 页
- Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity · SiM · 2025-11-27 · 在第 3 页
- A Tutorial for Propensity Score Weighting Methods Under Violations of the Positivity Assumption · SiM · 2025-11-27 · 在第 4 页
- A Bayesian Parametric and Nonparametric Approach for the Imputation of Multivariate Left‐Censored Data Due to Limit of Detection · SiM · 2025-11-27 · 在第 4 页
- Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials · SiM · 2025-11-25 · 在第 4 页
- Assessment of Wiener Process Degradation Models With Application to Amyotrophic Lateral Sclerosis Decline · SiM · 2025-11-20 · 在第 4 页
- An Information Criterion Approach for Assessing Agreement When Comparing Two Methods of Measurement · SiM · 2025-11-20 · 在第 4 页
- A Bayesian Two‐Step Multiple Imputation Approach Based on Mixed Models for Missing EMA Data · SiM · 2025-11-19 · 在第 4 页
- Causal Inference for First Non‐Fatal Events With the Competing Risk of Death: A Principal Stratification Approach · SiM · 2025-11-18 · 在第 4 页
- Optimality Considerations in Two‐Stage Biomarker‐Stratified Trials With Adaptive Enrichment · SiM · 2025-11-17 · 在第 4 页
- Estimating Causal Treatment Effects in the Sequential Parallel Comparison Design (SPCD) · SiM · 2025-11-17 · 在第 4 页
- Model‐Twin Randomization (MoTR) for Estimating the Recurring Individual Treatment Effect · SiM · 2025-11-12 · 在第 4 页
- A Proposal for Homoskedastic Modeling With Conditional Auto‐Regressive Distributions · SiM · 2025-11-11 · 在第 4 页
- On “Confirmatory” Methodological Research in Statistics and Related Fields · SiM · 2025-11-10 · 在第 4 页
- Modeling Alzheimer's Disease Biomarkers' Trajectory in the Absence of a Gold Standard Using a Bayesian Approach · SiM · 2025-11-10 · 在第 4 页
- Inference About Separable Causal Effects With Longitudinal Bivariate Ordinal Responses With Missingness and Censoring · SiM · 2025-11-10 · 在第 4 页
- Regression Adjustment in Covariate‐Adaptive Randomized Experiments With Missing Covariates · SiM · 2025-11-07 · 在第 4 页
- Regional Consistency Evaluation and Sample Size Calculation Under Two MRCTs · SiM · 2025-11-07 · 在第 4 页
- Independent Increments and Group Sequential Tests · SiM · 2025-11-07 · 在第 4 页
- Identification of Regions of Interest in Neuroimaging Data With Irregular Boundary Based on Semiparametric Transformation Models and Interval‐Censored Outcomes · SiM · 2025-11-07 · 在第 4 页
- Estimation of Interventional Effects in Clinical Trials With a Repeatedly Measured Mediator · SiM · 2025-11-07 · 在第 4 页
- A Sensitivity Analysis Framework Using the Proxy Pattern–Mixture Model for Generalization of Experimental Results · SiM · 2025-11-07 · 在第 4 页
- A Modification to Two‐Stage Least Squares With Genetic Applications · SiM · 2025-11-07 · 在第 4 页
- Adaptive Sparsening and Smoothing of the Treatment Model for Longitudinal Causal Inference Using Outcome-Adaptive LASSO and Marginal Fused LASSO · SiM · 2025-11-05 · 在第 5 页
- Modeling the Role of Baseline Risk and Additional Study‐Level Covariates in Meta‐Analysis of Treatment Effects · SiM · 2025-10-23 · 在第 5 页
- Combined P ‐Value Functions for Compatible Effect Estimation and Hypothesis Testing in Drug Regulation · SiM · 2025-10-23 · 在第 5 页
- ChatGPT as a Tool for Biostatisticians: A Tutorial on Applications, Opportunities, and Limitations · SiM · 2025-10-23 · 在第 5 页
- Collaborative Inference for Accelerated Failure Time Model Using Clinical Center‐Level Summary Statistics · SiM · 2025-10-22 · 在第 5 页
- Ordinal Sparse Neural Networks for Modeling Gene‐ and Imaging‐Environment Interactions · SiM · 2025-10-17 · 在第 6 页
- Determining the Optimal Sequence of Multiple Tests · SiM · 2025-10-17 · 在第 6 页
- Measuring Agreement in Diagnostics: A Practical Guide for Researchers · SiM · 2025-10-16 · 在第 6 页
- False Discovery Estimation in Record Linkage · SiM · 2025-10-16 · 在第 6 页
- Dynamic Prediction Using Functional Latent Trait Joint Models for Multivariate Longitudinal Outcomes: An Application to Parkinson's Disease · SiM · 2025-10-16 · 在第 6 页
- Specification of Estimands for Complex Disease Processes Using Multistate Models and Utility Functions · SiM · 2025-10-14 · 在第 6 页
- Doubly Robust Estimators for Heterogeneous Treatment Effects in Heteroskedastic Survival Data · SiM · 2025-10-12 · 在第 6 页
- Covariate Balancing With Measurement Error · SiM · 2025-10-11 · 在第 6 页
- A Noise‐Tolerant Inference Procedure for Quasi‐Monte Carlo Likelihood Estimation of a Joint Model for Multiple Longitudinal Markers and Competing Risks · SiM · 2025-10-11 · 在第 6 页
- Rethinking the Handling of Method Failure in Comparison Studies · SiM · 2025-10-09 · 在第 6 页
- An Approach to Design Adaptive Clinical Trials With Time‐to‐Event Outcomes Based on a General Bayesian Posterior Distribution · SiM · 2025-10-09 · 在第 6 页
- Adaptive Biomarker‐Based Design for Early Phase Clinical Trials · SiM · 2025-10-09 · 在第 6 页
- What's the Weight? Estimating Controlled Outcome Differences in Complex Surveys for Health Disparities Research · SiM · 2025-10-07 · 在第 7 页
- Sensitivity Analyses for Missing in Repeatedly Measured Outcome Data · SiM · 2025-10-07 · 在第 7 页
- Robust Estimation of Additive Shared‐Frailty Models for Recurrent Event Data With Dependent Censoring · SiM · 2025-10-07 · 在第 7 页
- Estimating and Evaluating Counterfactual Prediction Models · SiM · 2025-10-07 · 在第 7 页
- Estimating Risk Factors for Pathogenic Dose Accrual From Longitudinal Data · SiM · 2025-10-07 · 在第 7 页
- Difference‐in‐Differences for Health Policy and Practice: A Review of Modern Methods · SiM · 2025-10-07 · 在第 7 页
- Deep Mixture of Linear Mixed Models for Complex Longitudinal Data · SiM · 2025-10-07 · 在第 7 页
- Accounting for Misclassification of Cause of Death in Weighted Cumulative Incidence Functions for Causal Analyses · SiM · 2025-10-07 · 在第 7 页
- A Practical Framework to Design Immunization Studies Based on the Beta Distribution · SiM · 2025-10-07 · 在第 7 页
- A New Test for Assessing the Covariate Effect in ROC Curves · SiM · 2025-10-07 · 在第 7 页
- A Corrected Score Approach for Proportional Hazards Model With Error‐Contaminated Covariates Subject to Detection Limits · SiM · 2025-10-07 · 在第 7 页
- Nothing to See Here? A Non-Inferiority Approach to Parallel Trends · SiM · 2025-09-30 · 在第 8 页
- Analysis of Stepped‐Wedge Cluster Randomized Trials When Treatment Effects Vary by Exposure Time or Calendar Time · SiM · 2025-09-24 · 在第 8 页
- Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’” · SiM · 2025-09-23 · 在第 8 页
- Gaussian Process Regression for Value‐Censored Functional and Longitudinal Data · SiM · 2025-09-23 · 在第 8 页
- Futility Analyses for the MCP ‐Mod Methodology Based on Longitudinal Models · SiM · 2025-09-23 · 在第 8 页
- Designing Stepped Wedge Cluster Randomized Trials With a Baseline Measurement of the Outcome · SiM · 2025-09-23 · 在第 8 页
- Causal Machine Learning Methods and Use of Cross‐Fitting in Settings With High‐Dimensional Confounding · SiM · 2025-09-23 · 在第 8 页
- Logistic Mixed‐Effects Model Analysis With Pseudo‐Observations for Estimating Risk Ratios in Clustered Binary Data Analysis · SiM · 2025-09-22 · 在第 8 页
- Group Sequential Trial Design Using Stepwise Monte Carlo for Increased Flexibility and Robustness · SiM · 2025-09-22 · 在第 8 页
- Double Negative Control Inference With Some Invalid Negative Control Exposures for Continuous Outcome · SiM · 2025-09-22 · 在第 8 页
- Biostatisticians Meet AI : Navigating Shifts While Preserving Principles · SiM · 2025-09-22 · 在第 8 页
- Model‐Free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival · SiM · 2025-09-19 · 在第 8 页
- Model‐Robust Standardization in Cluster‐Randomized Trials · SiM · 2025-09-18 · 在第 8 页
- The Estimand Framework in Diagnostic Accuracy Studies · SiM · 2025-09-17 · 在第 8 页
- Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout · SiM · 2025-09-17 · 在第 8 页
- Towards Efficient Time‐to‐Event Dose‐Escalation Guidance of Multi‐Cycle Cancer Therapies · SiM · 2025-09-16 · 在第 8 页
- What Is Fair? Defining Fairness in Machine Learning for Health · SiM · 2025-09-15 · 在第 8 页
- Weighted Trigonometric Regression for Suboptimal Designs in Circadian Transcriptome Studies · SiM · 2025-09-15 · 在第 8 页
- Impact of Endpoint Delay on the Efficiency of Multi Arm Multi Stage Trials · SiM · 2025-09-15 · 在第 8 页
- Collapsible Kernel Machine Regression for Exposomic Analyses · SiM · 2025-09-15 · 在第 8 页
- Tutorial on Bayesian Functional Regression Using Stan · SiM · 2025-09-14 · 在第 9 页
- Power and Sample Size Calculation for Multivariate Longitudinal Trials Using the Longitudinal Rank Sum Test · SiM · 2025-09-14 · 在第 9 页
- Bayesian Adaptive Enrichment Design for Continuous Biomarkers · SiM · 2025-09-14 · 在第 9 页
- Hierarchical Grouped Horseshoe Priors for Subgroup Identification and Estimation · SiM · 2025-09-11 · 在第 9 页
- Accounting for Misclassification of Binary Outcomes in External Control Arm Studies for Unanchored Indirect Comparisons: Simulations and Applied Example · SiM · 2025-09-10 · 在第 9 页
- Using Confidence Distributions in Final and Interim Analyses for Single‐Arm Studies or Platform Trials Consisting of Single‐Arm Studies · SiM · 2025-09-09 · 在第 9 页
- Minimum Area Confidence Set Optimality for Simultaneous Confidence Bands for Percentiles With Applications to Drug Shelf‐Life Estimation · SiM · 2025-09-09 · 在第 9 页
- Testing for Similarity of Dose Response in Multiregional Clinical Trials · SiM · 2025-09-08 · 在第 9 页
- A New Algorithm for Sampling Parameters in a Structured Correlation Matrix With Application to Estimating Optimal Combinations of Muscles to Quantify Progression in Duchenne Muscular Dystrophy · SiM · 2025-09-08 · 在第 9 页
- Equivalency Between the Generalized Bivariate Bernoulli Model Dependency Test and a Logistic Regression Model With Interaction Effects · SiM · 2025-09-07 · 在第 9 页
- A Bayesian Multi‐Factorial Design and Analysis for Estimating Combined Effects of Multiple Interventions in a Pragmatic Clinical Trial to Improve Dementia Care · SiM · 2025-09-07 · 在第 9 页
- RISE: Two‐Stage Rank‐Based Identification of High‐Dimensional Surrogate Markers Applied to Vaccinology · SiM · 2025-09-05 · 在第 9 页
- Multiplicity Control in Oncology Clinical Trials With a Binary Surrogate Endpoint‐Based Drop‐The‐Losers Design · SiM · 2025-09-05 · 在第 9 页
- Modeling Joint Health Effects of Environmental Exposure Mixtures With Bayesian Additive Regression Trees · SiM · 2025-09-05 · 在第 9 页
- Incorporating Heterogeneity in Mixed Hidden Markov Models With an Application to the Sleep‐Wake Cycle · SiM · 2025-09-05 · 在第 9 页
- A Multi‐Phenotype Approach to Joint Testing of Main Genetic and Gene‐Environment Interaction Effects · SiM · 2025-09-05 · 在第 9 页
- A Location‐Scale Joint Model for Studying the Link Between the Time‐Dependent Subject‐Specific Variability of Blood Pressure and Competing Events · SiM · 2025-09-05 · 在第 9 页
- Semiparametric Efficient Inference for the Probability of Necessary and Sufficient Causation · SiM · 2025-08-28 · 在第 10 页
- Augmenting Treatment Arms With External Data Through Propensity‐Score Weighted Power Priors: An Application in Expanded Access · SiM · 2025-08-26 · 在第 10 页
- Dynamic Long‐Term Prediction With Intermediate Event Information: A Flexible Model With Bivariate Time‐Varying Coefficients · SiM · 2025-08-23 · 在第 10 页
- Testing and Estimation of Treatment Effects in Clinical Trials for Terminal and Nonterminal Events Subject to Competing Risks · SiM · 2025-08-22 · 在第 10 页
- Semiparametric Inference for a Two‐Phase Failure‐Time‐Auxiliary‐Dependent Sampling Design · SiM · 2025-08-22 · 在第 10 页
- Prior Effective Sample Size When Borrowing on the Treatment Effect Scale · SiM · 2025-08-22 · 在第 10 页
- Complex Network and Topological Data Analysis Methods for County Level COVID‐19 Vaccine Acceptance Analysis in the United States · SiM · 2025-08-22 · 在第 10 页
- Accommodating Spatial Heterogeneity in Geographically Weighted Regression with Group Penalty · SiM · 2025-08-20 · 在第 10 页
- Flexible Empirical Bayesian Approaches to Pharmacovigilance for Simultaneous Signal Detection and Signal Strength Estimation in Spontaneous Reporting Systems Data · SiM · 2025-08-19 · 在第 10 页
- Biomarker Combination Based on the Youden Index With and Without Gold Standard · SiM · 2025-08-19 · 在第 10 页
- The Cox Model With Adaptive Fused Group Bridge Penalty to Incorporate Historical Data Into the Analysis of Clinical Trials With an Application to BMT CTN 1101 · SiM · 2025-08-16 · 在第 10 页
- Score Test for Functional Markov Process With Image Predictor · SiM · 2025-08-16 · 在第 10 页
- Generalized Method of Moments in Analyzing Recurrent Events for Semiparametric Transformation Models With Informative Censoring · SiM · 2025-08-16 · 在第 10 页
- Nonparametric Estimation of Transition Intensities in Interval‐Censored Markov Multistate Models Without Loops · SiM · 2025-08-15 · 在第 10 页
- Cumulative Logit Ordinal Regression With Proportional Odds Under Nonignorable Missing Responses—Application to Phase III Trial · SiM · 2025-08-14 · 在第 10 页
- An Efficient Two‐Dimensional Functional Mixed‐Effect Model Framework for Repeatedly Measured Functional Data · SiM · 2025-08-14 · 在第 10 页
- A Framework for Generating Realistic Synthetic Tabular Data in a Randomized Controlled Trial Setting · SiM · 2025-08-13 · 在第 10 页
- Nonparametric Estimation of the Potential Impact Fraction and the Population Attributable Fraction With Individual‐Level and Aggregated Data · SiM · 2025-08-12 · 在第 10 页
- Multilevel Regression and Poststratification Using Margins of Poststratifiers: Improving Inference for HIV Health Outcomes During the COVID‐19 Pandemic · SiM · 2025-08-12 · 在第 10 页
- Estimation of Multi‐Category Youden Index Based on the Lehmann Assumption · SiM · 2025-08-12 · 在第 10 页
- Doubly Robust Estimation of Marginal Cumulative Incidence Curves for Competing Risk Analysis · SiM · 2025-08-08 · 在第 11 页
- Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance · SiM · 2025-08-08 · 在第 11 页
- Confidence Intervals for Adaptive Trial Designs I: A Methodological Review · SiM · 2025-08-08 · 在第 11 页
- Addressing Population Heterogeneity for HIV Incidence Estimation Based on Recency Test · SiM · 2025-08-08 · 在第 11 页
- scCOSMIX: A Mixed‐Effects Framework for Differential Coexpression and Transcriptional Interactions Modeling in Single‐Cell RNA‐Seq · SiM · 2025-08-07 · 在第 11 页
- Random Survival Forest With Multiple Imputation Analysis for Case‐Cohort and Generalized Case‐Cohort Studies · SiM · 2025-08-07 · 在第 11 页
- Poisson Beta Regression for Count Data With an Application to Hospital Length of Stay Data · SiM · 2025-08-07 · 在第 11 页
- Novel Clinical Trial Design With Stratum‐Specific Endpoints and Global Test Methods for Rare Diseases With Heterogeneous Clinical Manifestations · SiM · 2025-08-07 · 在第 11 页
- Health Utility Survival for Randomized Clinical Trials: Extensions and Statistical Properties · SiM · 2025-08-07 · 在第 11 页
- Constructing a T ‐Test for Value Function Comparison of Individualized Treatment Regimes in the Presence of Multiple Imputation for Missing Data · SiM · 2025-08-07 · 在第 11 页
- Combining Missing Data Imputation and Internal Validation in Clinical Risk Prediction Models · SiM · 2025-08-07 · 在第 11 页
- Bayesian Expectile Joint Model With Varying Coefficient for Longitudinal and Semi‐Competing Risks Data · SiM · 2025-08-07 · 在第 11 页
- Assessing Covariate Balance With Small Sample Sizes · SiM · 2025-08-07 · 在第 11 页
- A Unified Framework for Modeling Feedback and Endogeneity in Longitudinal Binary Outcomes Using Bayesian Methods · SiM · 2025-08-07 · 在第 11 页
- A Statistical Method for Benefit–Risk Assessment in Clinical Trials · SiM · 2025-08-07 · 在第 11 页
- A Primer on Inference and Prediction With Epidemic Renewal Models and Sequential Monte Carlo · SiM · 2025-08-07 · 在第 11 页
- A New Dirichlet‐Multinomial Mixture Regression Model for the Analysis of Microbiome Data · SiM · 2025-08-07 · 在第 11 页
- A Bayesian Mixture of Exponential Family Factor Models for Uncovering Disease Progression Subtypes · SiM · 2025-08-07 · 在第 11 页
- Multiple Imputation of Missing Covariates When Using the Fine–Gray Model · SiM · 2025-07-24 · 在第 13 页
- Fast Variational Bayesian Inference for Correlated Survival Data: An Application to Invasive Mechanical Ventilation Duration Analysis · SiM · 2025-07-24 · 在第 13 页
- The Mathematics of Serocatalytic Models With Applications to Public Health Data · SiM · 2025-07-22 · 在第 13 页
- Separable Effects of Semicompeting Risks: The Effects of Hepatitis B on Liver Cancer via Liver Cirrhosis · SiM · 2025-07-21 · 在第 13 页
- Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring · SiM · 2025-07-21 · 在第 13 页
- Confidence Intervals for AUC and pAUC by Empirical Likelihood · SiM · 2025-07-21 · 在第 13 页
- An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing With Concurrent Controls in Platform Trials · SiM · 2025-07-21 · 在第 13 页
- A Simple Diagnostic for the Positivity Assumption for Continuous Exposures · SiM · 2025-07-21 · 在第 13 页
- A General Linear Mixed Effect Model to Infer Biomarker Correlations by Bridging Retrospectively Measured Data Across Multiple Studies · SiM · 2025-07-21 · 在第 13 页
- Neural Network‐Based Dynamic Prediction for Interval‐Censored Data With Time‐Varying Covariates: Application to Alzheimer's Disease · SiM · 2025-07-18 · 在第 13 页
- Model Validation for Survival Analysis by Smoothed Predictive Likelihood · SiM · 2025-07-18 · 在第 13 页
- Exposure Measurement Error Correction in Longitudinal Studies With Discrete Outcomes · SiM · 2025-07-18 · 在第 13 页
- Performance of Cross‐Validated Targeted Maximum Likelihood Estimation · SiM · 2025-07-17 · 在第 13 页
- An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties · SiM · 2025-07-17 · 在第 13 页
- A Maximum Likelihood Method for High‐Dimensional Structural Equation Modeling · SiM · 2025-07-17 · 在第 14 页
- α$$ \alpha $$‐KIDS: A Novel Feature Evaluation in the Ultrahigh‐Dimensional Right‐Censored Setting, With Application to Head and Neck Cancer · SiM · 2025-07-15 · 在第 14 页
- Transfer Learning for Error‐Contaminated Poisson Regression Models · SiM · 2025-07-15 · 在第 14 页
- Time‐Varying Bayesian Network Meta‐Analysis · SiM · 2025-07-15 · 在第 14 页
- The Design of Large‐Scale Plasma Donation Trials · SiM · 2025-07-15 · 在第 14 页
- Subgroup Testing in the Change‐Plane Cox Model · SiM · 2025-07-15 · 在第 14 页
- Simultaneous Feature Selection for Optimal Dynamic Treatment Regimens · SiM · 2025-07-15 · 在第 14 页
- Sample Size Calculations for Partially Clustered Trials · SiM · 2025-07-15 · 在第 14 页
- Robust Transfer Learning for High‐Dimensional GLM Using γ$$ \gamma $$‐Divergence With Applications to Cancer Genomics · SiM · 2025-07-15 · 在第 14 页
- Robust Bayesian Inference in the Multilevel Zero‐Inflated Generalized Poisson Model · SiM · 2025-07-15 · 在第 14 页
- Penalized Reduced Rank Regression for Multi‐Outcome Survival Data Supports a Common Metabolic Risk Score for Age‐Related Diseases · SiM · 2025-07-15 · 在第 14 页
- Optimal Linear Combination of Biomarkers by Weighted Youden Index Maximization · SiM · 2025-07-15 · 在第 14 页
- Natural Effects in the Presence of an Intermediate Confounder: Evaluation of Pragmatic Estimation Strategies With an Emphasis on the Relationship Between Natural and Interventional Effects · SiM · 2025-07-15 · 在第 14 页
- MARGO: Machine Learning‐Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights · SiM · 2025-07-15 · 在第 14 页
- Integrating Misclassified EHR Outcomes With Validated Outcomes From a Non‐Probability Sample · SiM · 2025-07-15 · 在第 14 页
- Incorporation of Patient and Public Involvement in Statistical Methodology Research: Summary of Workshop Proceedings · SiM · 2025-07-15 · 在第 14 页
- Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment · SiM · 2025-07-15 · 在第 14 页
- Assessing Mediation in Cross‐Sectional Stepped Wedge Cluster Randomized Trials · SiM · 2025-07-15 · 在第 14 页
- An Efficient Estimation Method for Additive Subdistribution Hazards Model With Left‐Truncated Competing Risks Data Under the Case‐Cohort Study Design · SiM · 2025-07-15 · 在第 14 页
- Agreement Between Two Quantitative Measurement Methods When the Underlying Latent Trait Is Not Constant · SiM · 2025-07-15 · 在第 14 页
- Adjusting for Selection Bias Due to Missing Data in Electronic Health Records‐Based Research by Blending Multiple Imputation and Inverse Probability Weighting · SiM · 2025-07-15 · 在第 14 页
- Accounting for Patient Characteristics in a Model‐Based Kappa of Agreement Between Two Experts' Ordinal Ratings · SiM · 2025-07-15 · 在第 14 页
- A Note on the Sample Size Formula for a Win Ratio Endpoint · SiM · 2025-07-15 · 在第 14 页
- A Latent‐Class Model for Time‐To‐Event Outcomes and High‐Dimensional Imaging Data · SiM · 2025-07-15 · 在第 14 页
- A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design · SiM · 2025-07-15 · 在第 14 页
- Outlier Detection in Mendelian Randomization · SiM · 2025-07-14 · 在第 14 页
- Multivariate Adjustments for Average Equivalence Testing · SiM · 2025-07-14 · 在第 14 页
- Ascertainment Conditional Maximum Likelihood for Continuous Outcome Under Two‐Phase Response‐Selective Design · SiM · 2025-07-14 · 在第 14 页
- To Explain, to Predict, or to Describe: Figuring out the Study Goal [Commentary on “On the Uses and Abuses of Regression Models” by Carlin and Moreno‐Betancur] · SiM · 2025-06-24 · 在第 15 页
- Some Ways to Make Regression Modeling More Helpful Than Misleading · SiM · 2025-06-24 · 在第 15 页
- On the Uses and Abuses of Regression Models: A Call for Reform of Statistical Practice and Teaching · SiM · 2025-06-24 · 在第 15 页
- Commentary: Teaching Statistics as Minor Subject—Handing on Fire, Not Worshipping Ashes · SiM · 2025-06-24 · 在第 15 页
- Optimal Allocation of Observations in Stepped‐Wedge and Other Cluster Studies With Correlated Cluster‐Period Effects · SiM · 2025-06-23 · 在第 15 页
- Precision of Treatment Hierarchy: A Metric for Quantifying Certainty in Treatment Hierarchies From Network Meta‐Analysis · SiM · 2025-06-21 · 在第 15 页
- Testing for a General Changepoint in Medical and Psychometric Studies: Changes Detection and Sample Size Planning · SiM · 2025-06-13 · 在第 16 页
- Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A Tutorial · SiM · 2025-06-13 · 在第 16 页
- Futility Monitoring in Clinical Trials · SiM · 2025-06-11 · 在第 16 页
- Consistency‐Based Approach to Adjust for Multiplicity in Confirmatory Subgroup Analysis · SiM · 2025-06-11 · 在第 16 页
- The Impact of Violation of the Proportional Hazards Assumption on the Calibration of the Cox Proportional Hazards Model · SiM · 2025-06-10 · 在第 16 页
- Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants · SiM · 2025-06-10 · 在第 16 页
- Multiple Imputation Confidence Intervals for a Risk Difference With Missing Observations · SiM · 2025-06-10 · 在第 16 页
- Bayesian Estimation of Partial Functional Tobit Censored Quantile Regression Model · SiM · 2025-06-10 · 在第 16 页
- Semiparametric Estimation of Relative Causal Effects in Randomized Controlled Trials With Noncompliance · SiM · 2025-06-07 · 在第 16 页
- Sample Size Assessment and Interim Analysis Strategies for Survival Trial Designs With Covariate‐Adaptive Randomization · SiM · 2025-06-07 · 在第 16 页
- A Comparison Between Markov Switching Zero‐Inflated and Hurdle Models for Spatio‐Temporal Infectious Disease Counts · SiM · 2025-06-06 · 在第 16 页
- A Bayesian Approach to the G‐Formula via Iterative Conditional Regression · SiM · 2025-06-06 · 在第 16 页
- Statistical Inference for Tensor‐Based Covariates in Cox Regression Modeling in Integrated Genome Studies · SiM · 2025-06-05 · 在第 16 页
- Radiomics of PET Using Neural Networks for Prediction of Alzheimer's Disease Diagnosis · SiM · 2025-06-05 · 在第 16 页
- Integrating Multiple Data Sources With Interactions in Multi‐Omics Using Cooperative Learning · SiM · 2025-06-05 · 在第 16 页
- High‐Dimensional Multiresponse Partially Functional Linear Regression · SiM · 2025-06-05 · 在第 16 页
- Dynamic Information Borrowing From External Data in Clinical Trials: The Elastic Commensurate Prior Approach · SiM · 2025-06-05 · 在第 16 页
- Bland–Altman Plot for Censored Variables · SiM · 2025-06-05 · 在第 17 页
- BEAM: Bayesian Hybrid Design With Adaptive Sample Size Through Multisource Exchangeability Modeling · SiM · 2025-06-05 · 在第 17 页
- A Two‐Stage Method for Extending Inferences From a Collection of Trials · SiM · 2025-06-05 · 在第 17 页
- Improving the Modeling of Binary Response Regression Based on New Proposals for Statistical Diagnostics With Applications to Medical Data · SiM · 2025-06-04 · 在第 17 页
- Using a Supervised Principal Components Analysis for Variable Selection in High‐Dimensional Datasets Reduces False Discovery Rates · SiM · 2025-06-03 · 在第 17 页
- Predictive Probabilities Made Simple: A Fast and Accurate Method for Clinical Trial Decision‐Making · SiM · 2025-06-03 · 在第 17 页
- False Discovery Rate Control for Confounder Selection Using Mirror Statistics · SiM · 2025-06-03 · 在第 17 页
- Exploring Causal Effects of Hormone‐ and Radio‐Treatments in an Observational Study of Breast Cancer Using Copula‐Based Semi‐Competing Risks Models · SiM · 2025-06-03 · 在第 17 页
- Dynamic Prediction of an Event Using Multiple Longitudinal Markers: A Model Averaging Approach · SiM · 2025-06-03 · 在第 17 页
- A Seamless Hybrid Phase II/III Design With Bayesian Interim Subgroup Selection · SiM · 2025-06-03 · 在第 17 页
- Sharp Variance Estimator and Causal Bootstrap in Stratified Randomized Experiments · SiM · 2025-05-30 · 在第 17 页
- A Bayesian Hierarchical Mixture Cure Modelling Framework to Utilize Multiple Survival Datasets for Long‐Term Survivorship Estimates: A Case Study From Previously Untreated Metastatic Melanoma · SiM · 2025-05-30 · 在第 17 页
- Personalized Biopsy Schedules Using an Interval‐Censored Cause‐Specific Joint Model · SiM · 2025-05-26 · 在第 18 页
- Integrating Complex Selection Rules Into the Latent Overlapping Group Lasso for the Construction of Coherent Prediction Models · SiM · 2025-05-26 · 在第 18 页
- Weighted Repeated Measures Correlation Coefficient: A New Correlation Coefficient for Handling Missing Data With Repeated Measures · SiM · 2025-05-23 · 在第 18 页
- Randomization‐Based Inference for MCP‐Mod · SiM · 2025-05-22 · 在第 18 页
- Optimal Surrogate‐Assisted Sampling for Cost‐Efficient Validation of Electronic Health Record Outcomes · SiM · 2025-05-22 · 在第 18 页
- M‐Learning for Individual Treatment Rule With Survival Outcomes · SiM · 2025-05-22 · 在第 18 页
- Estimation and Inference for the Additive Mean Residual Life Model With Change Point in the Continuous Covariate · SiM · 2025-05-22 · 在第 18 页
- Dynamic Single‐Index Scalar‐On‐Function Model · SiM · 2025-05-22 · 在第 18 页
- Confidence Intervals and Sample Size for the ICC in Two‐Way ANOVA Models · SiM · 2025-05-22 · 在第 18 页
- An Alternative Measure for Quantifying the Heterogeneity in Meta‐Analysis · SiM · 2025-05-22 · 在第 18 页
- Adjusted Nelson–Aalen Estimators by Inverse Treatment Probability Weighting With an Estimated Propensity Score · SiM · 2025-05-22 · 在第 18 页
- Accounting for Carryover Toxicity in Phase I Clinical Trials with Intra‐Patient Dose Escalation · SiM · 2025-05-22 · 在第 18 页
- A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine · SiM · 2025-05-22 · 在第 18 页
- Response to the Commentary on “Experimental Design and Power Calculation in Omics Circadian Rhythmicity Detection Using the Cosinor Model” · SiM · 2025-05-21 · 在第 18 页
- Minding Averages: Comment on “Experimental Design and Power Calculation in Omics Circadian Rhythmicity Detection Using the Cosinor Model” by Zong et al · SiM · 2025-05-21 · 在第 18 页
- The Whys, Whens, and Hows of Futility Monitoring · SiM · 2025-05-20 · 在第 18 页
- A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events · SiM · 2025-05-20 · 在第 18 页
- Why Recommended Visit Intervals Should Be Extracted When Conducting Longitudinal Analyses Using Electronic Health Record Data: Examining Visit Mechanism and Sensitivity to Assessment Not at Random · SiM · 2025-05-19 · 在第 18 页
- UNITED: A Unified Transparent and Efficient Phase I/II Trial Design for Dose Optimization Accounting for Ordinal Graded, Continuous and Mixed Toxicity and Efficacy Endpoints · SiM · 2025-05-19 · 在第 19 页
- TODO: A Triple‐Outcome Double‐Criterion Optimal Design for Dose Monitoring‐and‐Optimization in Multi‐Dose Randomized Trials · SiM · 2025-05-19 · 在第 19 页
- Surrogate Marker Evaluation: A Tutorial Using R · SiM · 2025-05-19 · 在第 19 页
- Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints · SiM · 2025-05-19 · 在第 19 页
- Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non‐Inferiority · SiM · 2025-05-19 · 在第 19 页
- Multi‐Study Factor Regression Model: An Application in Nutritional Epidemiology · SiM · 2025-05-19 · 在第 19 页
- Interconnections of Multimorbidity‐Related Clinical Outcomes: Analysis of Health Administrative Claims Data With a Dynamic Network Approach · SiM · 2025-05-19 · 在第 19 页
- Integrative Multi‐Omics and Multivariate Longitudinal Data Analysis for Dynamic Risk Estimation in Alzheimer's Disease · SiM · 2025-05-19 · 在第 19 页
- Inference for Cumulative Incidences and Treatment Effects in Randomized Controlled Trials With Time‐to‐Event Outcomes Under ICH E9 (R1) · SiM · 2025-05-19 · 在第 19 页
- Continuous‐Time Causal Inference With Marked Point Process Weights: An Example on Sodium‐Glucose Co‐Transporters 2 Inhibitor Medications and Urinary Tract Infection · SiM · 2025-05-19 · 在第 19 页
- Closed MCP‐Mod for Pairwise Comparisons of Several Doses With a Control · SiM · 2025-05-19 · 在第 19 页
- Causal Inference With Outcomes Truncated by Death and Missing Not at Random · SiM · 2025-05-19 · 在第 19 页
- COMIC: A Bayesian Dose Optimization Design for Drug Combination in Multiple Indications With Application to CAR‐T Therapies · SiM · 2025-05-19 · 在第 19 页
- Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials · SiM · 2025-05-19 · 在第 19 页
- An Augmented Approach for Regression Analysis of Case‐Cohort Interval‐Censored Failure Time Data · SiM · 2025-05-19 · 在第 19 页
- Adjustment of Conditional Bias in Hazard Ratios for Group Sequential Testing of Progression‐Free Survival and Overall Survival · SiM · 2025-05-19 · 在第 19 页
- A Co‐Segmentation Algorithm to Predict Emotional Stress From Passively Sensed mHealth Data · SiM · 2025-05-19 · 在第 19 页
- Risk‐Profile Based Monitoring Intervals for Multivariate Longitudinal Biomarker Measurements and Competing Events With Applications in Stable Heart Failure · SiM · 2025-05-16 · 在第 19 页
- Integrating Multimodal EHR Data for Mortality Prediction in ICU Sepsis Patients · SiM · 2025-05-16 · 在第 19 页
- Improved Pharmacovigilance Signal Detection Using Bayesian Generalized Linear Mixed Models · SiM · 2025-05-16 · 在第 19 页
- Bayesian Estimation of Hierarchical Linear Models From Incomplete Data: Cluster‐Level Interaction Effects and Small Sample Sizes · SiM · 2025-05-16 · 在第 19 页
- Accounting for Inconsistent Use of Covariate Adjustment in Group Sequential Trials · SiM · 2025-05-16 · 在第 19 页
- A Personalized Predictive Model That Jointly Optimizes Discrimination and Calibration · SiM · 2025-05-16 · 在第 19 页
- Prediction Modeling With Many Correlated and Zero‐Inflated Predictors: Assessing the Nonnegative Garrote Approach · SiM · 2025-04-25 · 在第 20 页
- Joint Latent Class Models: A Tutorial on Practical Applications in Clinical Research · SiM · 2025-04-25 · 在第 20 页
- Improving Efficiency and Robustness of the Prognostic Accuracy of Biomarkers With Partial Incomplete Failure‐Time Data and Auxiliary Outcome: Application to Prostate Cancer Active Surveillance Study · SiM · 2025-04-25 · 在第 20 页
- Identifying Less Burdensome and More Cost‐Efficient Incomplete Stepped Wedge Designs for Continuous Outcomes Collected via Repeated Cross‐Sections · SiM · 2025-04-25 · 在第 20 页
- Extensions of Heterogeneity in Integration and Prediction (HIP) With R Shiny Application · SiM · 2025-04-25 · 在第 20 页
- Evaluation of Rolling Surveillance Methods in Context of Prior Aberrations: A Simulation Study With Routine Data From Low‐ and Middle‐Income Countries · SiM · 2025-04-25 · 在第 20 页
- Bayesian Longitudinal Network Regression With Application to Brain Connectome Genetics · SiM · 2025-04-25 · 在第 20 页
- A Variance Estimator for Marginal Cox Regression Models Fit to Non‐Nested Multilevel Data · SiM · 2025-04-25 · 在第 20 页
- A Joint Model for (Un)Bounded Longitudinal Markers, Competing Risks, and Recurrent Events Using Patient Registry Data · SiM · 2025-04-25 · 在第 20 页
- Single‐Index Measurement Error Jump Regression Model in Alzheimer's Disease Studies · SiM · 2025-04-14 · 在第 20 页
- Combining Straight‐Line and Map‐Based Distances to Investigate the Connection Between Proximity to Healthy Foods and Disease · SiM · 2025-04-14 · 在第 21 页
- Bayesian Generalized Linear Models for Analyzing Compositional and Sub‐Compositional Microbiome Data via EM Algorithm · SiM · 2025-04-14 · 在第 21 页
- Instrumental Variable Methods to Target Hypothetical Estimands With Longitudinal Repeated Measures Data: Application to the STEP 1 Trial · SiM · 2025-04-11 · 在第 21 页
- Frequentist Grouped Weighted Quantile Sum Regression for Correlated Chemical Mixtures · SiM · 2025-04-11 · 在第 21 页
- Dynamic Treatment Effect Analysis in Crossover Designs Through Repeated Measures · SiM · 2025-04-11 · 在第 21 页
- A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight · SiM · 2025-04-11 · 在第 21 页
- A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes · SiM · 2025-04-11 · 在第 21 页
- Measuring the Performance of Survival Models to Personalize Treatment Choices · SiM · 2025-04-10 · 在第 21 页
- Exploring the Transitivity Assumption in Network Meta‐Analysis: A Novel Approach and Its Implications · SiM · 2025-04-10 · 在第 21 页
- Estimation of Cancer Incidence Trends Adjusted for Changes in Screening and Detection Processes · SiM · 2025-04-09 · 在第 21 页
- Analysis of Covariance in General Factorial Designs Through Multiple Contrast Tests Under Variance Heteroscedasticity · SiM · 2025-04-09 · 在第 21 页
- Causal Multistate Models to Evaluate Treatment Delay · SiM · 2025-04-08 · 在第 21 页
- BayTetra : A Bayesian Semiparametric Approach for Testing Trajectory Differences · SiM · 2025-04-08 · 在第 21 页
- A Robust Score Test in G‐Computation for Covariate Adjustment in Randomized Clinical Trials Leveraging Different Variance Estimators via Influence Functions · SiM · 2025-04-08 · 在第 21 页
- Global Sensitivity Analysis for Studies Extending Inferences From a Randomized Trial to a Target Population · SiM · 2025-03-24 · 在第 22 页
- Variable Selection for Progressive Multistate Processes Under Intermittent Observation · SiM · 2025-03-20 · 在第 23 页
- Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches · SiM · 2025-03-20 · 在第 23 页
- Overcoming Model Uncertainty — How Equivalence Tests Can Benefit From Model Averaging · SiM · 2025-03-19 · 在第 23 页
- A New Semiparametric Power‐Law Regression Model With Long‐Term Survival, Change‐Point Detection and Regularization · SiM · 2025-03-19 · 在第 23 页
- Incorporating Additional Evidence as Prior Information to Resolve Non‐Identifiability in Bayesian Disease Model Calibration: A Tutorial · SiM · 2025-03-18 · 在第 23 页
- Identification and Estimation of Causal Effects Using Non‐Concurrent Controls in Platform Trials · SiM · 2025-03-17 · 在第 23 页
- Group Sequential Test for Two‐Sample Ordinal Outcome Measures · SiM · 2025-03-17 · 在第 23 页
- Ensemble of Sequential Learning Models With Distributed Data Centers and Its Applications · SiM · 2025-03-17 · 在第 23 页
- Adaptive Weight Selection for Time‐To‐Event Data Under Non‐Proportional Hazards · SiM · 2025-03-17 · 在第 23 页
- Preservation of Type I Error for Partially‐Unblinded Sample Size Re‐Estimation · SiM · 2025-03-14 · 在第 23 页
- Bayesian Additive Regression Trees for Group Testing Data · SiM · 2025-03-14 · 在第 23 页
- Pattern Mixture Sensitivity Analyses via Multiple Imputations for Non‐Ignorable Dropout in Joint Modeling of Cognition and Risk of Dementia · SiM · 2025-03-13 · 在第 23 页
- Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time‐To‐Event Outcomes · SiM · 2025-03-13 · 在第 23 页
- Bayesian Calibration of Stochastic Agent Based Model via Random Forest · SiM · 2025-03-13 · 在第 23 页
- Estimation and Hypothesis Testing of Strain‐Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID‐19 Vaccine Trial · SiM · 2025-03-12 · 在第 24 页
- Semiparametric Modeling of Biomarker Trajectory and Variability With Correlated Measurement Errors · SiM · 2025-03-10 · 在第 24 页
- Efficient Computation of High‐Dimensional Penalized Piecewise Constant Hazard Random Effects Models · SiM · 2025-03-10 · 在第 24 页
- Can the Unit Size Predict Outcomes? Testing for Informativeness in Three‐Level Designs · SiM · 2025-03-10 · 在第 24 页
- A Spline‐Based Approach to Smoothly Constrain Hazard Ratios With a View to Apply Treatment Effect Waning · SiM · 2025-03-09 · 在第 24 页
- Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints · SiM · 2025-03-06 · 在第 24 页
- Modelling Volume‐Outcome Relationships in Health Care · SiM · 2025-03-05 · 在第 24 页
- Causal Inference in Presence of Intra‐Patient Correlation due to Repeated Measurements of Exposure and Outcome in Longitudinal Settings · SiM · 2025-03-05 · 在第 24 页
- Analyzing Coarsened and Missing Data by Imputation Methods · SiM · 2025-03-05 · 在第 24 页
- Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo · SiM · 2025-03-05 · 在第 24 页
- A Seamless Design for the Combination of a Case–Control and a Cohort Diagnostic Accuracy Study · SiM · 2025-03-05 · 在第 24 页
- Estimating Mean Viral Load Trajectory From Intermittent Longitudinal Data and Unknown Time Origins · SiM · 2025-02-25 · 在第 24 页
- A Novel Approach to Assess the Predictiveness of a Continuous Biomarker in Early Phases of Drug Development · SiM · 2025-02-25 · 在第 24 页
- Modeling the Restricted Mean Survival Time Using Pseudo‐Value Random Forests · SiM · 2025-02-22 · 在第 25 页
- A Double Machine Learning Approach for the Evaluation of COVID‐19 Vaccine Effectiveness Under the Test‐Negative Design: Analysis of Québec Administrative Data · SiM · 2025-02-21 · 在第 25 页
- Jointly Modeling Time‐To‐Event and Longitudinal Data With Individual‐Specific Change Points: A Case Study in Modeling Tumor Burden · SiM · 2025-02-20 · 在第 25 页
- Identification and Estimation of the Average Causal Effects Under Dietary Substitution Strategies · SiM · 2025-02-20 · 在第 25 页
- A Graph‐Theoretic Approach to Detection of Parkinsonian Freezing of Gait From Videos · SiM · 2025-02-20 · 在第 25 页
- A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards · SiM · 2025-02-20 · 在第 25 页
- Proportional Mean Residual Life Model With Varying Coefficients for Right Censored Data · SiM · 2025-02-19 · 在第 25 页
- Network Meta‐Analysis With Individual Participant‐Level Data of Time‐to‐Event Outcomes Using Cox Regression · SiM · 2025-02-18 · 在第 25 页
- Individualized Time‐Varying Nonparametric Model With an Application in Mobile Health · SiM · 2025-02-18 · 在第 25 页
- Dir‐GLM: A Bayesian GLM With Data‐Driven Reference Distribution · SiM · 2025-02-18 · 在第 25 页
- Bayesian Hierarchical Penalized Spline Models for Immediate and Time‐Varying Intervention Effects in Stepped Wedge Cluster Randomized Trials · SiM · 2025-02-18 · 在第 25 页
- Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling · SiM · 2025-02-18 · 在第 25 页
- Adaptive Use of Co‐Data Through Empirical Bayes for Bayesian Additive Regression Trees · SiM · 2025-02-18 · 在第 25 页
- Testing for the Functional Form of a Continuous Covariate in the Shared‐Parameter Joint Model · SiM · 2025-02-17 · 在第 25 页
- Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology · SiM · 2025-02-14 · 在第 25 页
- So Many Choices: A Guide to Selecting Among Methods to Adjust for Observed Confounders · SiM · 2025-02-13 · 在第 25 页
- Random Survival Forest for Censored Functional Data · SiM · 2025-02-10 · 在第 26 页
- Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies · SiM · 2025-02-10 · 在第 26 页
- RMST for Interval‐Censored Data in Oncology Clinical Trials · SiM · 2025-02-08 · 在第 26 页
- Instability of the AUROC of Clinical Prediction Models · SiM · 2025-02-08 · 在第 26 页
- Challenges for Predictive Modeling With Neural Network Techniques Using Error‐Prone Dietary Intake Data · SiM · 2025-02-08 · 在第 26 页
- DOD ‐ SSR : An Adaptive Seamless Phase II / III Design With Dose Optimization Decision and Sample Size Re‐estimation · SiM · 2025-02-07 · 在第 26 页
- Applying the Estimands Framework to Non‐Inferiority Trials: Guidance on Choice of Hypothetical Estimands for Non‐Adherence and Comparison of Estimation Methods · SiM · 2025-02-07 · 在第 26 页
- scRecover : Discriminating True and False Zeros in Single‐Cell RNA ‐Seq Data for Imputation · SiM · 2025-02-06 · 在第 26 页
- Time‐Dependent ROC Curve for Multiple Longitudinal Biomarkers and Its Application in Diagnosing Cardiovascular Events · SiM · 2025-02-06 · 在第 26 页
- Statistical Inference for Association Studies in the Presence of Binary Outcome Misclassification · SiM · 2025-02-06 · 在第 26 页
- Optimal Control of Directional False Discovery Rates in Large‐Scale Testing · SiM · 2025-02-06 · 在第 26 页
- Inverse Probability of Treatment Weighting Using the Propensity Score With Competing Risks in Survival Analysis · SiM · 2025-02-06 · 在第 26 页
- Estimating Average Treatment Effects With Support Vector Machines · SiM · 2025-02-06 · 在第 26 页
- A General Framework to Assess Complex Heterogeneity in the Strength of a Surrogate Marker · SiM · 2025-02-06 · 在第 26 页
- A Calibrated Sensitivity Analysis for Weighted Causal Decompositions · SiM · 2025-02-06 · 在第 26 页
- Causal Mediation Analysis: A Summary‐Data Mendelian Randomization Approach · SiM · 2025-02-05 · 在第 26 页
- Regression—A Means, Not an End · SiM · 2025-02-04 · 在第 26 页
- The Harms of Class Imbalance Corrections for Machine Learning Based Prediction Models: A Simulation Study · SiM · 2025-01-26 · 在第 27 页
- Hierarchical Multi‐Label Classification With Gene‐Environment Interactions in Disease Modeling · SiM · 2025-01-26 · 在第 27 页
- Bayesian Analysis of Censored Linear Mixed‐Effects Models for Heavy‐Tailed Irregularly Observed Repeated Measures · SiM · 2025-01-26 · 在第 27 页
- A Bayesian Joint Model of Multiple Nonlinear Longitudinal and Competing Risks Outcomes for Dynamic Prediction in Multiple Myeloma: Joint Estimation and Corrected Two‐Stage Approaches · SiM · 2025-01-26 · 在第 27 页
- Improving the Effectiveness of Sample Size Re‐Estimation: An Operating Characteristic Focused, Hybrid Frequentist‐Bayesian Approach · SiM · 2025-01-25 · 在第 27 页
- Adjusting for Ascertainment Bias in Meta‐Analysis of Penetrance for Cancer Risk · SiM · 2025-01-25 · 在第 27 页
- Testing Covariates Effects on Bivariate Reference Regions · SiM · 2025-01-24 · 在第 27 页
- Supervised Functional Principal Component Analysis Under the Mixture Cure Rate Model: An Application to Alzheimer'S Disease · SiM · 2025-01-24 · 在第 27 页
- Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials · SiM · 2025-01-24 · 在第 27 页
- Reference‐Based Multiple Imputation for Longitudinal Binary Data · SiM · 2025-01-24 · 在第 27 页
- On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs · SiM · 2025-01-24 · 在第 27 页
- Non‐Parametric Estimation for Semi‐Competing Risks Data With Event Misascertainment · SiM · 2025-01-24 · 在第 27 页
- Nonparametric Path‐Specific Effects on a Survival Outcome Through Multiple Time‐to‐Event Mediators · SiM · 2025-01-24 · 在第 27 页
- Evaluating Meta‐Learners to Analyze Treatment Heterogeneity in Survival Data: Application to Electronic Health Records of Pediatric Asthma Care in COVID‐19 Pandemic · SiM · 2025-01-24 · 在第 27 页
- Estimation of Diagnostic Test Accuracy Without Gold Standards · SiM · 2025-01-24 · 在第 27 页
- Between‐ and Within‐Cluster Spearman Rank Correlations · SiM · 2025-01-24 · 在第 27 页
- Bayesian Spatial Relative Survival Model to Estimate the Loss in Life Expectancy and Crude Probability of Death for Cancer Patients · SiM · 2025-01-24 · 在第 27 页
- Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior · SiM · 2025-01-24 · 在第 27 页
- A Varying‐Coefficient Additive Hazard Model for Recurrent Events Data · SiM · 2025-01-24 · 在第 27 页
- A Simple Sensitivity Analysis Method for Unmeasured Confounders via Linear Programming With Estimating Equation Constraints · SiM · 2025-01-24 · 在第 27 页
- A Generalized Bayesian Stochastic Block Model for Microbiome Community Detection · SiM · 2025-01-24 · 在第 27 页
- A Bayesian Multivariate Model With Temporal Dependence on Random Partition of Areal Data for Mosquito‐Borne Diseases · SiM · 2025-01-24 · 在第 28 页
- Testing One Primary and Two Secondary Endpoints in a Two‐Stage Group Sequential Trial With Extensions · SiM · 2025-01-23 · 在第 28 页
- Reverse Time‐to‐Death as Time‐Scale in Time‐to‐Event Analysis for Studies of Advanced Illness and Palliative Care · SiM · 2025-01-23 · 在第 28 页
- Multiple Imputation for Longitudinal Data: A Tutorial · SiM · 2025-01-23 · 在第 28 页
- Bioequivalence Design With Sampling Distribution Segments · SiM · 2025-01-23 · 在第 28 页
- Allocation Predictability of Individual Assignments in Restricted Randomization Designs for Two‐Arm Equal Allocation Trials · SiM · 2025-01-23 · 在第 28 页
- Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis · SiM · 2025-01-22 · 在第 28 页
- Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data · SiM · 2025-01-22 · 在第 28 页